Eagle Pharmaceuticals Inc (EGRX) — Cash Flow Quality Index
Eagle Pharmaceuticals Inc (EGRX) has a Cash Flow Quality Index of -0.02x as of June 2023. Operating cash flow of $-126.00K is below net income of $5.16 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore balance sheet size of Eagle Pharmaceuticals Inc for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Eagle Pharmaceuticals Inc Cash Flow Quality Index (2015–2020)
Historical Cash Flow Quality Index for Eagle Pharmaceuticals Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check EGRX tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Eagle Pharmaceuticals Inc (2015–2020)
Year-by-year earnings quality comparison for Eagle Pharmaceuticals Inc. For live market cap and the full company financial profile, see EGRX company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 4.13x | $49.50 Million | $11.99 Million | ▲ +5.5% |
| 2019 | 3.91x | $55.99 Million | $14.31 Million | ▲ +138.2% |
| 2018 | 1.64x | $52.38 Million | $31.90 Million | ▲ +44.8% |
| 2017 | 1.13x | $58.92 Million | $51.94 Million | ▲ +73.6% |
| 2016 | 0.65x | $53.21 Million | $81.45 Million | ▲ +117.3% |
| 2015 | -3.78x | $-9.72 Million | $2.57 Million | — |